PubAg

Main content area

MLA

Sunasara, Khurram, et al. "Bivalent Rlp2086 (trumenba®): Development of a Well-characterized Vaccine Through Commercialization." Vaccine, v. 36,.22 pp. 3180-3189. doi: 10.1016/j.vaccine.2017.03.100

APA

Sunasara, K., Cundy, J., Srinivasan, S., Evans, B., Sun, W., Cook, S., Bortell, E., Farley, J., Griffin, D., Bailey Piatchek, M., & Arch-Douglas, K. (2018). Bivalent rLP2086 (Trumenba®): Development of a well-characterized vaccine through commercialization. Vaccine, 36, 3180-3189. doi: 10.1016/j.vaccine.2017.03.100

Chicago

Sunasara, Khurram, John Cundy, Sriram Srinivasan, Brad Evans, Weiqiang Sun, Scott Cook, Eric Bortell, et al. "Bivalent rLP2086 (Trumenba®): Development of a well-characterized vaccine through commercialization" Vaccine 36, no. 22 (2018): 3180-3189. doi: 10.1016/j.vaccine.2017.03.100